Resilience Government Services, Inc.
Resilience Government Services, Inc. received −$57K in federal prime contract obligations in the 12 months ending Oct 5, 2026, up 99.7% from −$20.1M the year before, and $110.3M since FY2022. Its largest customer is the Department of Defense.
Contractor details
- Unique Entity ID (UEI)
- GC2RFAZK8G64
- CAGE code
- 3GQS9
- Doing business as
- Nanotherapeutics
- Headquarters
- Alachua, FL
- Business size
- Other Than Small Business
As recorded on this UEI's most recent prime contract action in USAspending.gov. Confirm current registration and certifications in SAM.gov.
Obligations by fiscal year
Net prime contract obligations by federal fiscal year.
Top agencies
Funding agencies ranked by obligations since FY2022.
| Funding agency | Latest 12 mo | Since FY2022 |
|---|---|---|
| Department of Defense | $0 | $103.8M |
| Department of Health and Human Services | −$57K | $6.5M |
Top NAICS codes
Industry codes agencies recorded on this contractor's awards, since FY2022.
| NAICS | Industry | Latest 12 mo | Since FY2022 |
|---|---|---|---|
| 541715 | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | $0 | $101.8M |
| 541714 | Research and Development in Biotechnology (except Nanobiotechnology) | −$57K | $5.7M |
| 325412 | Pharmaceutical Preparation Manufacturing | $0 | $2.0M |
| 541711 | Research and Development in Biotechnology | $0 | $800K |
What it sells
Product and service codes (PSC) on this contractor's awards, since FY2022.
| PSC | Description | Since FY2022 |
|---|---|---|
| AN42 | Health R&D services; Health Care - other; Applied Research | $101.8M |
| AN12 | Health R&D services; Health Care services; Applied Research | $6.5M |
| AE37 | R&D- Economic growth: Manufacturing Technology (Commercialized) | $2.0M |
Recent awards
This contractor's newest prime contract awards, most recent first.
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| 75N93023F00001 | Department of Health and Human Services DEVELOPMENT OF LNA14 ANALYTICAL METHODS AND UPSTREAM AND DOWNSTREAM PROCESSES FOR MANUFACTURING, AND SCALE-UP MANUFACTURING AND RELEASE TESTING OF THE PURIFIED LNA14 PRODUCT | $485K | Aug 25, 2023 |
| W911SR23F0057 | Department of Defense DRUG SUBSTANCE (DS) PROCESS VALIDATION, DRUG PRODUCT (DP) PROCESS VALIDATION, CLINICAL DEVELOPMENT PHASE 3, AND STORAGE/STABILITY FOR THE PROGRAM WITH ULTIMATE GOAL OF U.S.… | $4.4M | Mar 8, 2023 |
| W911SR22F0073 | Department of Defense DS PROCESS CHARACTERIZATION | $2.4M | Jun 16, 2022 |
| W911SR22F0014 | Department of Defense CLINICAL DEVELOPMENT PHASE 2 STUDY | $18.7M | Jan 5, 2022 |
Prime contracts (award types A–D) from USAspending.gov through Oct 5, 2026. Subcontracts are not included. Net obligations include deobligations and corrections.
Ready to connect your pursuit work?
GovEagle gives BD directors, capture managers, and proposal teams one AI workspace from pipeline through proposal, with CMMC/FedRAMP Certified compliance built in.